Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma.

导出 OA

翻译打印收藏纠错

作者： Kevin J,Tu ^[1] ; Connor E,Stewart ^[2] ; Peter G,Hendrickson ^[3] ; Joshua A,Regal ^[1] ; So Young,Kim ^[1] ; David M,Ashley ^[1] ; Matthew S,Waitkus ^[4] ; Zachary J,Reitman ^[5]

作者单位： Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, 27710, USA. ^[1] Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 21044, USA. ^[2] Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. ^[3] Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA. ^[4] Duke Cancer Institute, Duke University School of Medicine, Durham, NC, 27710, USA. ^[5] Department of Neurosurgery, Duke University School of Medicine, Durham, NC, 27710, USA. ^[6] The Preston Robert Tisch Brain Tumor Center at Duke, Durham, NC, 27710, USA. ^[7] Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, 27710, USA. zjr@duke.edu. ^[8] Duke Cancer Institute, Duke University School of Medicine, Durham, NC, 27710, USA. zjr@duke.edu. ^[9] Department of Neurosurgery, Duke University School of Medicine, Durham, NC, 27710, USA. zjr@duke.edu. ^[10] The Preston Robert Tisch Brain Tumor Center at Duke, Durham, NC, 27710, USA. zjr@duke.edu. ^[11] Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA. zjr@duke.edu. ^[12]